Potential targeted therapy based on deep insight into the relationship between the pulmonary microbiota and immune regulation in lung fibrosis
Open Access
- 24 January 2023
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14, 1032355
Abstract
Pulmonary fibrosis is an irreversible disease, and its mechanism is unclear. The lung is a vital organ connecting the respiratory tract and the outside world. The changes in lung microbiota affect the progress of lung fibrosis. The latest research showed that lung microbiota differs in healthy people, including idiopathic pulmonary fibrosis (IPF) and acute exacerbation-idiopathic pulmonary fibrosis (AE-IPF). How to regulate the lung microbiota and whether the potential regulatory mechanism can become a necessary targeted treatment of IPF are unclear. Some studies showed that immune response and lung microbiota balance and maintain lung homeostasis. However, unbalanced lung homeostasis stimulates the immune response. The subsequent biological effects are closely related to lung fibrosis. Core fucosylation (CF), a significant protein functional modification, affects the lung microbiota. CF regulates immune protein modifications by regulating key inflammatory factors and signaling pathways generated after immune response. The treatment of immune regulation, such as antibiotic treatment, vitamin D supplementation, and exosome micro-RNAs, has achieved an initial effect in clearing the inflammatory storm induced by an immune response. Based on the above, the highlight of this review is clarifying the relationship between pulmonary microbiota and immune regulation and identifying the correlation between the two, the impact on pulmonary fibrosis, and potential therapeutic targets.Keywords
This publication has 129 references indexed in Scilit:
- The role of infection in the pathogenesis of idiopathic pulmonary fibrosisEuropean Respiratory Review, 2013
- Predictive functional profiling of microbial communities using 16S rRNA marker gene sequencesNature Biotechnology, 2013
- Functional characterization of pulmonary neuroendocrine cells in lung development, injury, and tumorigenesisProceedings of the National Academy of Sciences, 2012
- Molecular epidemiology of meticillin-resistant Staphylococcus aureus in Italian cystic fibrosis patients: A national overviewJournal of Cystic Fibrosis, 2011
- Unique carbohydrate–carbohydrate interactions are required for high affinity binding between FcγRIII and antibodies lacking core fucoseProceedings of the National Academy of Sciences, 2011
- The pre‐B cell receptor checkpointFEBS Letters, 2010
- Potent inhibition of microRNA in vivo without degradationNucleic Acids Research, 2008
- Stress, Drugs, and Evolution: the Role of Cellular Signaling in Fungal Drug ResistanceEukaryotic Cell, 2008
- The Structure of a Human Type III Fcγ Receptor in Complex with FcJournal of Biological Chemistry, 2001
- A Novel Mechanism for B Cell Repertoire Maturation Based on Response by B Cell Precursors to Pre–B Receptor AssemblyJournal of Experimental Medicine, 1998